News
The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...
The hits just keep on coming for Regeneron’s Eylea franchise. | The FDA has extended its target action dates for two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback